TRULICITY
Drug timelines are a Plus or Pro feature.
36 regulatory and trial events tracked for TRULICITY, covering 2014-09-18 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) [Phase 3]